Section Arrow
CLDX.NASDAQ
- Celldex Therapeutics
Quotes are at least 15-min delayed:2026/09/19 12:40 EDT
Regular Hours
Last
 38.24
-0.74 (-1.90%)
Day High 
38.87 
Prev. Close
38.98 
1-M High
43.2 
Volume 
2.08M 
Bid
37.5
Ask
41.81
Day Low
37.535 
Open
38.87 
1-M Low
36.84 
Market Cap 
3.06B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 38.73 
20-SMA 39.4 
50-SMA 39.14 
52-W High 45.14 
52-W Low 22.1 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-4.35/-4.24
Enterprise Value
3.06B
Balance Sheet
Book Value Per Share
9.10
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
1.55M
Operating Revenue Per Share
0.06
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
RXRXRecursion Pharmaceuticals3.83+0.29+8.19%-- 
TCRTAlaunos Therapeutics Inc.1.2-0.4-25.00%-- 
ROIVRoivant Sciences Ltd39.77-0.21-0.53%-- 
SLXNSilexion Therapeutics Corp.0.4355+0.0555+14.61%-- 
IOVAIovance Biotherapeutics10.25+0.23+2.30%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.